Amphion Innovations, which focuses on developing medical and technology businesses, has signed a partnership agreement with Kuwait University. The agreement is aimed at establishing and operating a Technology Transfer Unit (TTU) at the university. This facility will be the first in-house technology transfer facility in Kuwait.
Amphion sets up technology transfer office at Kuwait University
Amphion Innovations, which focuses on developing medical and technology businesses, has signed a partnership agreement with Kuwait University. The agreement is aimed at establishing and operating a Technology Transfer Unit (TTU) at the university. This facility will be the first in-house technology transfer facility in Kuwait.
More from Alimentary/Metabolic
More from Therapeutic Category
• By
Two potentially first-in-class molecules signify Zai Lab’s renewed drive for the in-house discovery of drugs that it requires “to be innovative, differentiated and to have the potential to make a big difference for patients,” its global R&D head tells Scrip.
• By
The company’s FcRn inhibitor nipocalimab was approved by the US FDA for generalized myasthenia gravis (gMG), where it will join a competitive market.
• By
Emma Walmsley tells Scrip that the "biotech market is under a certain degree of pressure," so reasonably priced deals are available.